Insights

Strategic partnerships Leverage recent collaboration with Tcelltech GmbH to co-develop personalized cell therapies, offering joint value propositions to biotech customers pursuing custom gene delivery solutions and expanded indication coverage.

New product launches Capitalize on launches like CellFE T-Rest for resting T cells and the upcoming high-volume clinical-scale instrument to target contract manufacturers and labs needing scalable, non-viral gene editing workflows.

Clinical and manufacturing focus Highlight the Ryva Mechanoporation system and scalable workflow capabilities to biotechs seeking faster, cost-reducing cell engineering processes; position as enabling faster time-to-patient for cell therapies.

Funding and leadership signals Leverage Series A backing and board additions to signal strong growth and credibility when engaging potential customers, partners, and clinical developers looking for proven, investor-backed tech.

Market readiness Target mid-sized biotechs and CROs preparing for clinical trials with high-value microfluidics platforms, offering training, integration support, and regulatory-friendly workflows to reduce risk and accelerate adoption.

Similar companies to CellFE

CellFE Tech Stack

CellFE uses 8 technology products and services including Quickbooks Online, SOLIDWORKS, Microsoft SharePoint, and more. Explore CellFE's tech stack below.

Media & News

CellFE's Email Address Formats

CellFE uses at least 2 email formats:
CellFE Email FormatsExamplePercentage
First@cellfebiotech.comJohn@cellfebiotech.com
94%
Last@cellfebiotech.comDoe@cellfebiotech.com
6%

Frequently Asked Questions

What is CellFE's official website and social media links?

Minus sign iconPlus sign icon
CellFE's official website is cellfebiotech.com and has social profiles on LinkedIn.

How much revenue does CellFE generate?

Minus sign iconPlus sign icon
As of October 2026, CellFE's annual revenue is estimated to be $1M - $10M.

What is CellFE's SIC code and NAICS code?

Minus sign iconPlus sign icon
CellFE's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CellFE have currently?

Minus sign iconPlus sign icon
As of October 2026, CellFE has approximately 20 employees across 2 continents, including North America and Europe. Key team members include Member Board Of Directors: C. U. and Senior Field Applications Scientist: K. C. V. Explore CellFE's employee directory with LeadIQ.

What industry does CellFE belong to?

Minus sign iconPlus sign icon
CellFE operates in the Biotechnology Research industry.

What technology does CellFE use?

Minus sign iconPlus sign icon
CellFE's tech stack includes Quickbooks Online, SOLIDWORKS, Microsoft SharePoint, Squarespace, WordPress, Squarespace Commerce, Box and Vimeo.

What is CellFE's email format?

Minus sign iconPlus sign icon
CellFE's email format typically follows the pattern of First@cellfebiotech.com. Find more CellFE email formats with LeadIQ.

How much funding has CellFE raised to date?

Minus sign iconPlus sign icon
As of October 2026, CellFE has raised $28M in funding. The last funding round occurred on Jan 30, 2025.

When was CellFE founded?

Minus sign iconPlus sign icon
CellFE was founded in 2018.
CellFE logo

CellFE

Biotechnology ResearchCalifornia, United States11-50 Employees

CellFE is a biotechnology research startup based in Alameda, California that specializes in cell engineering for cell therapies. It has developed a microfluidic platform that enables efficient delivery of gene-editing molecules into cells while preserving viability, addressing a key bottleneck in therapy development and manufacturing. This technology broadens the range of therapies that can be developed and aims to reduce cost, simplify processes, and shorten production timelines, while seeking to improve the efficacy and safety of engineered cells.

Its customers include researchers and manufacturers pursuing next-generation and personalized cell therapies, seeking more scalable and reliable manufacturing workflows. In January 2025, CellFE announced the launch of CellFE T-Rest, a transfection medium designed for resting (quiescent) T cell workflows, reflecting its focus on complementary tools for cell therapy development.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $28M

    CellFE has raised a total of $28M of funding over 4 rounds. Their latest funding round was raised on Jan 30, 2025 as a Grant.

  • $1M - $10M

    CellFE's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.